The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Profound neuronal plasticity in response to inactivation of the dopamine transporter
Abstract
The dopamine transporter (DAT) plays an important role in calibrating the duration and intensity of dopamine neurotransmission in the central nervous system. We have used a strain of mice in which the gene for the DAT has been genetically deleted to identify the DAT’s homeostatic role. We find that removal of the DAT dramatically prolongs the lifetime (300 times) of extracellular dopamine. Within the time frame of neurotransmission, no other processes besides diffusion can compensate for the lack of the DAT, and the absence of the DAT produces extensive adaptive changes to control dopamine neurotransmission. Despite the absence of a clearance mechanism, dopamine extracellular levels were only 5 times greater than control animals due to a 95% reduction in content and a 75% reduction in release. Paradoxically, dopamine synthesis rates are doubled despite a decrease of 90% in the levels of tyrosine hydroxylase and degradation is markedly enhanced. Thus, the DAT not only controls the duration of extracellular dopamine signals but also plays a critical role in regulating presynaptic dopamine homeostasis. It is interesting to consider that the switch to a dopamine-deficient, but functionally hyperactive, mode of neurotransmission observed in mice lacking the DAT may represent an extreme example of neuronal plasticity resulting from long-term psychostimulant abuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Dalgleish, T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1432 · Cited by 1,849
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854
New concepts in cocaine addiction: The dopamine depletion hypothesis
Dackis, C. A., & Gold, M. S. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90022-3 · Cited by 607
Catecholamine metabolism: basic aspects and clinical significance.
Kopin, I. J. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06859-0 · Cited by 582
Research works printed but not linked: 39
- 10.1146/annurev.ne.16.030193.000445 · DOI · Paper page
- R S Feldman, J S Meyer, L F Quenzer Principles of Neuropsycho-Pharmacology (Sinauer, Sunderland, MA, , Chapt. 8 and 9. (1997).
- 10.1016/0301-0082(90)90033-D · DOI · Paper page
- 10.1523/JNEUROSCI.17-18-06899.1997 · DOI · Paper page
- 10.1523/JNEUROSCI.14-10-06084.1994 · DOI · Paper page
- 10.1002/med.2610150104 · DOI
- 10.1126/science.2820058 · DOI · Paper page
- 10.1038/386827a0 · DOI · Paper page
- I J Kopin Pharmacol Rev 37, 333–364 (1985).
- 10.1038/379606a0 · DOI · Paper page
- 10.1046/j.1471-4159.1995.64062581.x · DOI · Paper page
- 10.1016/0165-0270(93)90094-8 · DOI · Paper page
- U Ungerstedt Measurement of Neurotransmitter Release in Vivo, ed C A Marsden (Wiley, Chicester, U.K.), pp. 81–105 (1984).
- K B J Franklin, G Paxinos The Mouse Brain in Stereotaxic Coordinates (Academic, San Diego, 1997).
- 10.1016/0024-3205(90)90043-Q · DOI · Paper page
- 10.1016/0165-0270(93)90097-B · DOI · Paper page
- 10.1007/BF00508904 · DOI · Paper page
- 10.1016/0024-3205(76)90013-8 · doi:10.1016/0024-3205(76)90013-8
- 10.1007/BF01244343 · DOI
- 10.1006/abio.1993.1026 · doi:10.1006/abio.1993.1026
- 10.1016/0006-2952(80)90098-2 · doi:10.1016/0006-2952(80)90098-2
- J A Near Mol Pharmacol 30, 252–257 (1986).
- 10.1016/0006-8993(92)91003-W · DOI
- 10.1016/S0006-3495(95)80348-6 · DOI · Paper page
- J A Near, J C Bigelow, R M Wightman J Pharmacol Exp Ther 245, 921–927 (1988).
- 10.1016/0024-3205(81)90322-2 · DOI
- 10.1073/pnas.89.20.9593 · DOI
- S Spector, R Gordon, A Sjoerdsma, S Udenfriend Mol Pharmacol 3, 549–555 (1967).
- M E Wolf, R H Roth Presynaptic Receptors and the Question of Autoregulation of Neurotransmitter Release, eds S Kalsner, T C Westfall (NY Academy of Sciences, New York) 604, 323–343 (1990).
- 10.1016/0014-2999(76)90268-5 · DOI · Paper page
- 10.1016/0014-2999(88)90110-0 · DOI · Paper page
- M Goldstein Psychopharmacology: The Fourth Generation of Progress, eds F E Bloom, D J Kupfer (Raven, New York), pp. 189–195 (1995).
- 10.1016/0306-4522(94)90084-1 · DOI
- 10.1523/JNEUROSCI.14-01-00442.1994 · DOI · Paper page
- K Fuxe, L F Agnati Advances in Neuroscience, eds K Fuxe, L F Agnati (Raven, New York) 1, 1–10 (1991).
- M J Bannon, R L Michaud, R H Roth Mol Pharmacol 19, 270–275 (1981).
- 10.1212/WNL.47.3.718 · DOI · Paper page
- 10.1038/nm0696-699 · DOI · Paper page
- 10.1001/archpsyc.1986.01800020013003 · DOI · Paper page
Cited by
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Eisenhofer, G., Kopin, I. J., & Goldstein, D. S. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.1 · Cited by 1,072
“However, based on the data obtained in mice lacking catecholamine transporters (Jones et al., 1998; Xu et al., 2000), it seems likely that the low plasma levels of DHPG could also reflect decreased vesicular stores of norepinephrine.”
BackgroundInfluentialAn Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Self-citationPlasma membrane monoamine transporters: structure, regulation and function
Torres, G. E., Gainetdinov, R. R., & Caron, M. G. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1008 · Cited by 939
Self-citationRole of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885
Self-citationSLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Beaulieu, J.-M., Sotnikova, T. D., Yao, W.-D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 793
Self-citationPrefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 741
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697
Tian, H., Hammer, R. E., Matsumoto, A. M., Russell, D. W., & McKnight, S. L. (1998) · Genes & Development · doi:10.1101/gad.12.21.3320 · Cited by 647
Dopamine Is a Regulator of Arousal in the Fruit Fly
Kume, K., Kume, S., Park, S. K., Hirsh, J., & Jackson, F. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2048-05.2005 · Cited by 597
Cocaine self-administration in dopamine-transporter knockout mice
Rocha, B. A., Fumagalli, F., Gainetdinov, R. R., Jones, S. R., Ator, R., Giros, B., Miller, G. W., & Caron, M. G. (1998) · Nature Neuroscience · doi:10.1038/381 · Cited by 522
Self-citationHyperactivity and impaired response habituation in hyperdopaminergic mice
Zhuang, X., Oosting, R. S., Jones, S. R., Gainetdinov, R. R., Miller, G. W., Caron, M. G., & Hen, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1982 · Cited by 499
Self-citationProtective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants
Xu, F., Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Bohn, L. M., Miller, G. W., Wang, Y.-M., & Caron, M. G. (2000) · Nature Neuroscience · doi:10.1038/74839 · Cited by 464
Self-citationBäckman, C. M., Malik, N., Zhang, Y., Shan, L., Grinberg, A., Hoffer, B. J., Westphal, H., & Tomac, A. C. (2006) · genesis · doi:10.1002/dvg.20228 · Cited by 460
LEE, F. J. S., LIU, F., PRISTUPA, Z. B., & NIZNIK, H. B. (2001) · The FASEB Journal · doi:10.1096/fj.00-0334com · Cited by 455
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Wong, C., Hitzemann, R., & Pappas, N. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35115-8 · Cited by 422
Changes in the composition of brain interstitial ions control the sleep-wake cycle
Ding, F., O’Donnell, J., Xu, Q., Kang, N., Goldman, N., & Nedergaard, M. (2016) · Science · doi:10.1126/science.aad4821 · Cited by 387
Striatal dopamine neurotransmission: Regulation of release and uptake
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Basal Ganglia · doi:10.1016/j.baga.2016.02.001 · Cited by 382
Monoamine Transporters: From Genes to Behavior
Gainetdinov, R. R., & Caron, M. G. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.050802.112309 · Cited by 381
Self-citationVariation in dopamine genes influences responsivity of the human reward system
Dreher, J.-C., Kohn, P., Kolachana, B., Weinberger, D. R., & Berman, K. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805517106 · Cited by 376
Membrane Trafficking Regulates the Activity of the Human Dopamine Transporter
Melikian, H. E., & Buckley, K. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07699.1999 · Cited by 374
DAncing past the DAT at a DA synapse
Cragg, S. J., & Rice, M. E. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.03.011 · Cited by 374
Dopamine transporters and neuronal injury
Miller, G. W., Gainetdinov, R. R., Levey, A. I., & Caron, M. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01379-6 · Cited by 371
Self-citationThe Neurotransmitter Cycle and Quantal Size
Edwards, R. H. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.001 · Cited by 365
Lewis, D. A., Melchitzky, D. S., Sesack, S. R., Whitehead, R. E., Auh, S., & Sampson, A. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1092 · Cited by 352
Torres, G. E., Yao, W.-D., Mohn, A. R., Quan, H., Kim, K.-M., Levey, A. I., Staudinger, J., & Caron, M. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00267-7 · Cited by 344
Self-citationEisenhofer, G. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00144-9 · Cited by 342
Li, X., Patel, J. C., Wang, J., Avshalumov, M. V., Nicholson, C., Buxbaum, J. D., Elder, G. A., Rice, M. E., & Yue, Z. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5604-09.2010 · Cited by 341
Decision making in the ageing brain: changes in affective and motivational circuits
Samanez-Larkin, G. R., & Knutson, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3917 · Cited by 336
Chaudhry, F. A., Reimer, R. J., Krizaj, D., Barber, D., Storm-Mathisen, J., Copenhagen, D. R., & Edwards, R. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81674-8 · Cited by 331
Striatal dopamine transporters and cognitive functioning in healthy men and women
Mozley, L. H., Gur, R. C., Mozley, P. D., & Gur, R. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1492 · Cited by 314
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Zahniser, N. R., & Doolen, S. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00158-9 · Cited by 310
Gomeza, J., Ohno, K., Hülsmann, S., Armsen, W., Eulenburg, V., Richter, D. W., Laube, B., & Betz, H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00673-1 · Cited by 298
Gomeza, J., Hülsmann, S., Ohno, K., Eulenburg, V., Szöke, K., Richter, D., & Betz, H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00672-x · Cited by 294
Costa, R. M., Lin, S.-C., Sotnikova, T. D., Cyr, M., Gainetdinov, R. R., Caron, M. G., & Nicolelis, M. A. L. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.030 · Cited by 284
Self-citationSchizophrenia: from phenomenology to neurobiology
Wong, A. H. C., & Van Tol, H. H. M. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00035-6 · Cited by 280
Marchitti, S. A., Deitrich, R. A., & Vasiliou, V. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.1 · Cited by 280
Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00305.2001 · Cited by 271
“Of note was the lack of disruption in PPI in DAT (1/2) mice, which have an intermediate expression of the DAT and a corresponding intermediate elevation of extracellular DA levels [twofold increase compared with fivefold in DAT (2/2)], as well as decreases in DA release, uptake, and tissue concentrations relative to D…”
BackgroundSelf-citationAbolished cocaine reward in mice with a cocaine-insensitive dopamine transporter
Chen, R., Tilley, M. R., Wei, H., Zhou, F., Zhou, F.-M., Ching, S., Quan, N., Stephens, R. L., Hill, E. R., Nottoli, T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600905103 · Cited by 277
Mathews, T. A., Fedele, D. E., Coppelli, F. M., Avila, A. M., Murphy, D. L., & Andrews, A. M. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.05.017 · Cited by 276
Yavich, L., Forsberg, M. M., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0665-07.2007 · Cited by 269
Gainetdinov, R. R., Jones, S. R., Fumagalli, F., Wightman, R. M., & Caron, M. G. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00063-5 · Cited by 268
Self-citationIdentification and Characterization of a Novel Monoamine Transporter in the Human Brain
Engel, K., Zhou, M., & Wang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407913200 · Cited by 267
Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266
Self-citationGerber, D. J., Sotnikova, T. D., Gainetdinov, R. R., Huang, S. Y., Caron, M. G., & Tonegawa, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261583798 · Cited by 264
Self-citationMorón, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08480.2003 · Cited by 262
“Although pharmacological and genetic ablation (Grace, 1995; Jones et al., 1998) studies indicate a critical role of DAT in the maintenance of DA neuronal homeostasis, the endogenous mechanisms regulating DAT expression and activity are poorly understood.”
Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice
Chen, L., Cagniard, B., Mathews, T., Jones, S., Koh, H. C., Ding, Y., Carvey, P. M., Ling, Z., Kang, U. J., & Zhuang, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413955200 · Cited by 261
Self-citationLoder, M. K., & Melikian, H. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301845200 · Cited by 260
Romero, L. M., & Remage-Healey, L. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7491 · Cited by 259
Animal models of attention-deficit hyperactivity disorder.
Davids, E., Zhang, K., Tarazi, F. I., & Baldessarini, R. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00274-6 · Cited by 250
Cocaine Increases Dopamine Release by Mobilization of a Synapsin-Dependent Reserve Pool
Venton, B. J., Seipel, A. T., Phillips, P. E. M., Wetsel, W. C., Gitler, D., Greengard, P., Augustine, G. J., & Wightman, R. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4901-04.2006 · Cited by 246
Self-citationSchott, B. H., Seidenbecher, C. I., Fenker, D. B., Lauer, C. J., Bunzeck, N., Bernstein, H.-G., Tischmeyer, W., Gundelfinger, E. D., Heinze, H.-J., & Düzel, E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3463-05.2006 · Cited by 214
Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.
Goodwin, J. S., Larson, G. A., Swant, J., Sen, N., Javitch, J. A., Zahniser, N. R., De Felice, L. J., & Khoshbouei, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805298200 · Cited by 203
Dopamine transporters govern diurnal variation in extracellular dopamine tone
Ferris, M. J., España, R. A., Locke, J. L., Konstantopoulos, J. K., Rose, J. H., Chen, R., & Jones, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407935111 · Cited by 192
Self-citationLess is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome
Paulus, W., & Trenkwalder, C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70576-2 · Cited by 181
van der Wee, N. J., Stevens, H., Hardeman, J. A., Mandl, R. C., Denys, D. A., van Megen, H. J., Kahn, R. S., & Westenberg, H. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2201 · Cited by 149
“Higher transporter density may result from a higher homeostatic tone of the dopaminergic system, with lower densities of D1 and D2 receptors (33, 34).”
BackgroundSensation-seeking: dopaminergic modulation and risk for psychopathology
Norbury, A., & Husain, M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.015 · Cited by 142
Fujiwara, T., Mishima, T., Kofuji, T., Chiba, T., Tanaka, K., Yamamoto, A., & Akagawa, K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0289-06.2006 · Cited by 125
Why glycine transporters have different stoichiometries
Supplisson, S., & Roux, M. J. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03251-9 · Cited by 122
Characterization of A11 neurons projecting to the spinal cord of mice
Koblinger, K., Füzesi, T., Ejdrygiewicz, J., Krajacic, A., Bains, J. S., & Whelan, P. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109636 · Cited by 114
dela Peña, I., Gevorkiana, R., & Shi, W.-X. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.044 · Cited by 116
Trinh, J. V., Nehrenberg, D. L., Jacobsen, J. P. R., Caron, M. G., & Wetsel, W. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00165-9 · Cited by 113
Self-citationVolta, M., Beccano-Kelly, D. A., Paschall, S. A., Cataldi, S., MacIsaac, S. E., Kuhlmann, N., Kadgien, C. A., Tatarnikov, I., Fox, J., Khinda, J., et al. (2017) · eLife · doi:10.7554/elife.28377 · Cited by 108
Brunswick, D. J., Amsterdam, J. D., Mozley, P. D., & Newberg, A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1836 · Cited by 104
Comparison of the brain penetration injury associated with microdialysis and voltammetry
Jaquins-Gerstl, A., & Michael, A. C. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.06.023 · Cited by 98
The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining
Gonon, F. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.010 · Cited by 79
Hahn, T., Heinzel, S., Dresler, T., Plichta, M. M., Renner, T. J., Markulin, F., Jakob, P. M., Lesch, K., & Fallgatter, A. J. (2011) · Human Brain Mapping · doi:10.1002/hbm.21127 · Cited by 78
Salvatore, M. F., Calipari, E. S., & Jones, S. R. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00064 · Cited by 72
Self-citationChang, T. T., Yeh, T. L., Chiu, N. T., Chen, P. S., Huang, H. Y., Yang, Y. K., Lee, I. H., & Lu, R. B. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00771.x · Cited by 63
Vecchio, L. M., Sullivan, P., Dunn, A. R., Bermejo, M. K., Fu, R., Masoud, S. T., Gregersen, E., Urs, N. M., Nazari, R., Jensen, P. H., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15432 · Cited by 56
“Amphetamine treatment results in massive efflux of monoamines through their membrane transporters due to a reversal in the concentration gradient (Heal et al. 2013; Jones et al. 1998; Salahpour et al. 2008; Sulzer et al. 1995).”
BackgroundGaglia, M. M., & Kenyon, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3429-08.2009 · Cited by 49
Fulks, J. L., O’Bryhim, B. E., Wenzel, S. K., Fowler, S. C., Vorontsova, E., Pinkston, J. W., Ortiz, A. N., & Johnson, M. A. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100032f · Cited by 37
Strengths and limitations of genetic models of ADHD
Gainetdinov, R. R. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0021-3 · Cited by 24
“The mode of dopamine transmission in DAT-KO mice could be described as ‘‘volume transmission’’ which is distinguished by the markedly increased distance that released DA molecules can cover and thereby affect a wide area of postsynaptic receptors and structures (Jones et al. 1998; Zoli et al. 1999).”
BackgroundInfluentialSelf-citationCurtis, J. T., & Wang, Z. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.011 · Cited by 15
Effects of amphetamine on subcellular distribution of dopamine and DOPAC
Wallace, L. J. (2012) · Synapse · doi:10.1002/syn.21546 · Cited by 11
Metadata
- Authors
- Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., & Caron, M. G.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-03-31
- Volume
- 95
- Issue
- 7
- Pages
- 4029-4034
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 600
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.